About Us

Profile of PharmaAsia

The pharmaceutical industry in Asia is making big strides. With Big Pharma companies heading east, countries like India, China and Singapore continue to attract investments in R&D and manufacturing.

As PharmaAsia moves into its fourth year of publication, readers can continue to look forward to staying on-track with these rapid developments in Asia Pacific. With Asia's growing middle class and increasing purchasing power, PharmaAsia provides insights on how these market trends and demographic changes offer opportunities to expanding pharmaceutical companies.

In 2009, PharmaAsia launched a digital edition – delivering content in an electronic format that provides easy reader access and feedback. A print version of PharmaAsia will be delivered to subscribers three times a year timed during key tradeshows and events. It provides advertisers an excellent opportunity to capture the attention of readers and tradeshow delegates.

PharmaAsia's website is updated on a regular basis to keep readers up-to-date with the latest happenings in the industry. A weekly e-newsletter provides subscribers with a convenient snapshot of the latest industry news and events.

In 2010, PharmaAsia moves ahead in its tradition of editorial excellence with a range of featured topics such as biomarkers, pharmacovigilance, personalized medicine, data management and clinical trials management.

Understanding how decision makers are moving the industry is also imperative to business strategy. PharmaAsia continues to report on important developments in the region – with firsthand interviews with the man-at-the-helm of major companies.

As the industry continues to expand, PharmaAsia keeps track of the growth of auxiliary services and products such as cold chain management and information technology.

With technology advancing at breakneck pace, PharmaAsia discusses various technological issues at all levels – from drug discovery to development and production.

Equipped with an array of exciting topics, PharmaAsia is all set to continue its role as the leading resource for professionals and decision makers in the industry. Act now, to become partners with PharmaAsia in bringing the best of pharma to Asia and beyond.